Derek Bush

Director, National Accounts at Sarepta Therapeutics

Derek Bush has extensive experience in the pharmaceutical industry, with a focus on account management and market access. Derek has worked in various roles at different companies over the years.

Bush started their career at Innovex as a Sales Representative, promoting GSK pharmaceuticals to Family Practice and Internal Medicine physicians. Derek then joined GSK as a Sr. Sales Representative, where they promoted epilepsy, bipolar, Parkinson's, and depression pharmaceuticals to Neurologists and Psychiatrists.

After that, Bush moved to Allergan, PLC., where they held multiple positions. Derek served as a Regional Sales Manager, leading a team of representatives and being responsible for BOTOX sales and reimbursement. Derek also worked as a Regional Account Manager, handling market access for regional health plans and pharmaceutical contracting and negotiations. Derek was later promoted to Associate Director, National Accounts, overseeing key clients and product portfolios across various therapeutic areas.

Bush then joined Actavis (now Allergan), where they served as a Government Account Director. In this role, they managed government accounts and worked on medical policy and product launches.

Most recently, Bush has been working at Spark Therapeutics, Inc. Derek held the position of Gene Therapy Commercial Payer Lead - Midwest, where they received recognition for their account management skills. Derek then took on the role of Zone Lead - West, where they were responsible for coordinating and communicating zone performance and leading account management activities.

Currently, Bush is the Director of National Accounts at Sarepta Therapeutics, where they bring their expertise in account management to the organization.

Derek Bush obtained a Bachelor of Science degree in English for Information Systems from Dakota State University, where they studied from 1994 to 1998. Before that, they attended Luverne High School, but specific details about their degree or field of study are unavailable.


Previous companies

Spark Therapeutics logo


  • Director, National Accounts

    November, 2022 - present